Search Results

Disclosure Ref 2025136 - Utilisation of Insourcing for the following period 01012025 to 31032025.pdf

FOI Disclosure Ref 2025136 regarding the utilisation of insourcing for the following period 01012025 to 31032025

Disclosure Ref 2024239 - FOI Handling data .pdf

Freedom of Information disclosure reference 2024239 relating to number of FOI requests in 2023, those answered within the time limit & system tools used

HRP19 Management of Change Manager's Guide - Appendix 8 Outcome of Consultation - Changes Letter.docx

Disclosure Ref 2024245 - Collabrative working with pharmaceutical companies.pdf

Freedom of information disclosure relating to collaborative working with pharmaceutical companies

Tier 3 Specialist Weight Management Service Operational SOP (S157)

The guidance defines what the patient journey through the Tier 3 Specialist Weight Management Service should look like, including: • How referrals are received • How referrals out of the service are completed (to Tier 2 and Tier 4 services) • Clinical thresholds and triage criteria • Patient flow and program content • Prescribing initiation and transition points • MDT roles and responsibilities • Discharge process It also aims to ensure equitable access, clinical safety and consistency in triage and discharge decisions across localities.

Disclosure Ref 2025255 - Guidelines and policies relating to translation and Interrupting services.doc

Freedom of information disclosure relating to guidelines and policies relating to translation and Interrupting services

Disclosure Ref 2025296 - Permanent medical (e.g., Consultant or Specialty Doctor level) Recruitment Data.doc

Freedom of information disclosure relating to details of unfilled permanent medical vacancies, the number of permanent medical appointments made in the past 12 months, and the contact details of the person responsible for permanent medical recruitment.

Disclosure Ref 2025325 - Myeloma patients & specific drugs used.doc

Freedom of information disclosure relating to myeloma patients and the use of specific drugs used for treatment

Register_of_Board_Declarations_2020.21_v2.pdf

Declarations of interests - Board

Negative Pressure Wound Therapy Policy (P11)

The purpose of this policy is to provide evidence based guidance on the use of Negative Pressure Wound Therapy (NPWT), which is an advanced wound care treatment for patients with complex wounds. Clinicians working within Derbyshire Community Health Services NHS Trust should refer to this Policy for; • Recommended best practice guidance for managing a patient with NPWT. • Recommendations to reduce potential risk and harm to patients receiving NPWT. • The role of the Registered Healthcare Professional will be defined in this guideline, outlining their responsibility and accountability for the patient receiving NPWT